"Atrium Health Levine Cancer Institute provides access to top-ranked physician expertise, groundbreaking clinical trials and the latest cancer treatments across the Carolinas."

During the past decade, Batte Cancer Center at Northeast Medical Center conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 15 clinical trials were completed, i.e. on average, 500% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Batte Cancer Center at Northeast Medical Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 8 trials, followed by "Radiation Therapy Oncology Group" with 3 trials sponsored, "ETOP IBCSG Partners Foundation" with 2 trials sponsored, "Eastern Cooperative Oncology Group" with 2 trials sponsored and "NSABP Foundation Inc" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Batte Cancer Center at Northeast Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 19 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "Eli Lilly and Company" with 2 trials as a collaborator and "Radiation Therapy Oncology Group" with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Batte Cancer Center at Northeast Medical Center" are "Breast Cancer" (8 trials), "Lung Cancer" (3 trials), "Acute Leukemia" (2 trials), "Lymphoma" (2 trials) and "Multiple Myeloma" (2 trials). Many other conditions were trialed in "Batte Cancer Center at Northeast Medical Center" in a lesser frequency.

Most popular intervention types in "Batte Cancer Center at Northeast Medical Center" are "Drug" (18 trials), "Biological" (8 trials), "Radiation" (6 trials), "Other" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (5 trials), "bevacizumab" (4 trials), "paclitaxel" (4 trials), "cyclophosphamide" (3 trials) and "doxorubicin hydrochloride" (3 trials). Other intervention names were less common.

The vast majority of trials in "Batte Cancer Center at Northeast Medical Center" are 17 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Batte Cancer Center at Northeast Medical Center". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Batte Cancer Center at Northeast Medical Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Batte Cancer Center at Northeast Medical Center, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".